Briefpoint is a legal tech company that offers AI-powered software to automate and streamline the discovery process for legal professionals. It integrates with legal practice management software like Clio and Smokeball.
Docsum is an AI contract review and negotiation platform. With Docsum, legal, procurement, and sales teams can negotiate and manage contracts 3x faster, to reduce the time to close and win more deals. Docsum works by analyzing and redlining contracts using configurable playbooks owned by lawyers.
Recital is a legal tech company that utilizes AI to streamline contract management for in-house legal teams. It focuses on simplifying and accelerating the contract review process through features like clause extraction and suggestion, as well as automated contract organization and updates. Recital aims to address the challenges of growing workloads and tight deadlines faced by legal departments.
DocDraft is an AI-powered legal platform designed to assist small businesses and individuals with drafting legal documents. It offers features such as AI-powered document drafting, allowing users to generate customized legal documents in minutes, and aims to provide affordable, accessible, and customizable legal support. DocDraft utilizes AI to automate the creation of legal documents, streamlining the process and improving efficiency for legal professionals.
Syntheia automatically turns your contracts into data, and delivers that data where you need it, when you need it. Each of our apps is designed to fit existing workflows - reviewing documents, creating a clause bank, drafting documents and advice, and collaborating on work.
Lexis® Create+ leverages existing internal work products of legal professionals, delivering a powerful, personalized drafting experience in Microsoft 365. It is grounded in your firm’s DMS and authoritative LexisNexis® sources, with generative AI capabilities built right in. Connect the full knowledge of your firm with the unrivaled insights of LexisNexis for everything you need to quickly build exceptional legal documents while preserving firm confidentiality and privacy requirements.
Plaintiffs Dow Jones & Company, Inc., NYP Holdings, Inc., and corporate parent News Corporation have renewed their intellectual property (IP) complaint against artificial intelligence (AI)-powered “answer engine” Perplexity AI in the District Court for the Southern District of New York.
The court in Thomson Reuters v. Ross Intelligence granted Ross’s request for interlocutory appeal on whether Westlaw’s headnotes are original and if Ross’s limited use (0.076%) qualifies as fair use. The court acknowledged differing legal opinions on these core issues, which could reshape the trial and have major implications for AI and copyright law.
In its most recent effort to keep pace with advancing technology, the US Food and Drug Administration (FDA) recently issued two draft guidances on the use of artificial intelligence (AI) in the context of drugs, biologics, and medical devices.
As artificial intelligence (AI) continues to develop at a rapid pace, even the most sophisticated general counsel (GC) and in-house legal teams will be hard pressed to keep up with the evolving legal landscape.
In the last year, state activism in healthcare consumer protection has surged, with new laws that heighten oversight of for-profit investors’ engagement with healthcare marketplaces and scrutinize pharmaceutical pricing practices. As part of this activism, several state legislatures have enacted laws regulating use of artificial intelligence (AI) in healthcare delivery.
The CNIL issued draft guidelines to align AI training datasets with GDPR. Key principles include purpose limitation (clear, specific goals), data minimization, storage limits, and the need for a legal basis (e.g. consent or legitimate interest). Vague goals like “AI development” aren’t valid. The CNIL recommends ethics committees and traceable governance. Reuse of data requires compatibility with original purpose. This aims to balance innovation with data protection.